IMI (Innovative Medicine Initiative) 2 is the world's biggest public-private partnership (PPP) in the life sciences. Through the IMI 2 programme, it has a 3,3 billion of euros budget for the period 2014-2024.

The indicative topics under consideration for inclusion in the first call are:        

• Validation of translational imaging methods in drug safety assessment (TRISTAN)
• Identification of drugable targets modulating misfolded proteins in major neurodegenerative diseases
• Pathological neuron-glia interactions in neuropathic pain
• Dr